English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
CML highlights from EHA 2018 – treatment options in resistant CML patients, the role of IFN- α in the TKI era and treatment free remission
CML highlights from EHA 2018 – treatment options in resistant CML patients, the role of IFN- α in the TKI era and treatment free remission
August 2018 - As part of our educational service, we are delighted to present to you three new expert talks that were first presented during the 23rd Congress of the European Hematology Association. These presentations cover different aspects on CML management like treatment options in resistant CML patients, the role of IFN- α in the TKI era and TFR as a potential new treatment goal.
- Treatment options in resistant CML patients
(Professor Jane Apperley, London)
- Does IFN- α improve outcome of CML in the TKI era?
(Dr Franck-Emmanuel Nicolini, Paris)
- TFR – a new treatment goal of CP-CML patients?
(Dr Delphine Réa, Paris)
iCMLf Knowledge Centre - new eLearning tool for clinicians, molecular biologists and pathologists
iCMLf Knowledge Centre - new eLearning tool for clinicians, molecular biologists and pathologists
June 2018 - The iCMLf is delighted to announce the launch of the iCMLf Knowledge Centre, an interactive online resource providing educational content on CML. This new resource complements the other major online educational programs as part or our efforts to improve clinical practice and disease monitoring in CML worldwide through global education initiatives.
New edition of the iCMLf Newsletter - available now
June 2018 - We are delighted to present to you the new edition of the iCMLf Newsletter that features the Foundation's activities and programs over the last six months.
Download the pdf file here
Contents overview:
- News from the iCMLf - supporters and experts from the Foundation
- iCMLf progam update - news from our core programs and activities
- Summary of key publications - 5-year results from the phase II PACE trial
- iCMLf educational services - new interactive eLearning tool for CML
iCMLf Diagnosis and Testing Program - Apply now for 2018 grants
May 2018 - The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.
Over six years the iCMLf have awarded 48 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2018 the Foundation will offer 10 grants with funding of up to $10,000.
Applications will close on the 30th of July 2018. Proposals are welcome to arlene@cml-foundation.org.
Read more for further information on how to apply.
Michael Mauro and Giuseppe Saglio join the iCMLf Board of Directors
April 2018 - We are delighted to announce new members of the iCMLf board of Directors and Scientific Advisory Committee. The iCMLf was formed to assist the CML scientific community by leading haematologists in the field. As such, the trustees and advisors of the Foundation are all key CML experts. These people are critical to the strength of the iCMLf giving most generously of their time and expertise. In 2018 we welcome 2 new Directors and 4 new advisors to the iCMLf.
View new lectures on 'Future Directions for CML', 'TKI toxicities', and 'The CML frontier'
April 2018 - There are five new presentations on various aspects of CML management. All are recordings of leading expert presentations during a key-opinion leaders' meeting in Adelaide (Australia).
